Seuss+

Patients

In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLennan travelled to Nice for the Reuters Pharma event.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.